209 related articles for article (PubMed ID: 23587571)
1. Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.
Zhou F; Lauretti E; di Meco A; Ciric B; Gonnella P; Zhang GX; Rostami A
Immunobiology; 2013 Aug; 218(8):1069-76. PubMed ID: 23587571
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.
Zhou F; Ciric B; Zhang GX; Rostami A
Clin Exp Immunol; 2014 Dec; 178(3):447-58. PubMed ID: 25138204
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic cell-treated dendritic cells induce immune tolerance by specifically inhibiting development of CD4⁺ effector memory T cells.
Zhou F; Zhang GX; Rostami A
Immunol Res; 2016 Feb; 64(1):73-81. PubMed ID: 26111522
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
Mari ER; Rasouli J; Ciric B; Moore JN; Conejo-Garcia JR; Rajasagi N; Zhang GX; Rabinovich GA; Rostami A
Eur J Immunol; 2016 Jul; 46(7):1783-96. PubMed ID: 27151444
[TBL] [Abstract][Full Text] [Related]
5. Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells.
Kalantari T; Karimi MH; Ciric B; Yan Y; Rostami A; Kamali-Sarvestani E
Clin Exp Immunol; 2014 May; 176(2):180-9. PubMed ID: 24387596
[TBL] [Abstract][Full Text] [Related]
6. Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10(+) IFN-γ(+)-producing CD4(+) T cells.
Zhou F; Ciric B; Zhang GX; Rostami A
Immunol Res; 2013 May; 56(1):1-8. PubMed ID: 23292714
[TBL] [Abstract][Full Text] [Related]
7. 1,25-dihydroxyvitamin D
Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
[TBL] [Abstract][Full Text] [Related]
8. Selective depletion of CD11c
Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
[TBL] [Abstract][Full Text] [Related]
9. Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c
Kaushansky N; Kaminitz A; Allouche-Arnon H; Ben-Nun A
J Neuroimmunol; 2019 Aug; 333():476953. PubMed ID: 31108399
[TBL] [Abstract][Full Text] [Related]
10. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
11. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis.
Pennell LM; Fish EN
Immunology; 2017 Nov; 152(3):439-450. PubMed ID: 28646573
[TBL] [Abstract][Full Text] [Related]
12. Targeting DEC-205
Tabansky I; Keskin DB; Watts D; Petzold C; Funaro M; Sands W; Wright P; Yunis EJ; Najjar S; Diamond B; Cao Y; Mooney D; Kretschmer K; Stern JNH
Mol Med; 2018 May; 24(1):17. PubMed ID: 30134798
[TBL] [Abstract][Full Text] [Related]
13. Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.
Zhou Y; Leng X; Luo S; Su Z; Luo X; Guo H; Mo C; Zou Q; Liu Y; Wang Y
J Immunol Res; 2016; 2016():5021537. PubMed ID: 28070525
[TBL] [Abstract][Full Text] [Related]
14. LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4
Zhou F; Zhang GX; Rostami A
Immunol Res; 2017 Jun; 65(3):630-638. PubMed ID: 27942984
[TBL] [Abstract][Full Text] [Related]
15. Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c
Lu Y; Xu W; Gu Y; Chang X; Wei G; Rong Z; Qin L; Chen X; Zhou F
Front Immunol; 2019; 10():2829. PubMed ID: 31921114
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine-treated dendritic cells require STAT1 signaling for their tolerogenic activity.
Thome R; Bonfanti AP; Rasouli J; Mari ER; Zhang GX; Rostami A; Verinaud L
Eur J Immunol; 2018 Jul; 48(7):1228-1234. PubMed ID: 29572810
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific effector CD4 T lymphocytes school lamina propria dendritic cells to transfer innate tolerance.
Cascio JA; Haymaker CL; Divekar RD; Zaghouani S; Khairallah MT; Wan X; Rowland LM; Dhakal M; Chen W; Zaghouani H
J Immunol; 2013 Jun; 190(12):6004-14. PubMed ID: 23686493
[TBL] [Abstract][Full Text] [Related]
18. Spleen and liver dendritic cells differ in their tolerogenic and cytokine induction potential.
Mosayebi G; Moazzeni SM
Iran J Allergy Asthma Immunol; 2011 Sep; 10(3):163-70. PubMed ID: 21891822
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenic Dendritic Cells Generated by In Vitro Treatment With SAHA Are Not Stable In Vivo.
Thewissen K; Broux B; Hendriks JJ; Vanhees M; Stinissen P; Slaets H; Hellings N
Cell Transplant; 2016; 25(6):1207-18. PubMed ID: 26688298
[TBL] [Abstract][Full Text] [Related]
20. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties.
Miller G; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
J Immunol; 2003 Apr; 170(7):3554-64. PubMed ID: 12646617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
